CUSIP: 71714G102
Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
27,725,997
-
Share change
-
+1,555,767
-
Total reported value
-
$90,102,828
-
Put/Call ratio
-
0%
-
Price per share
-
$3.25
-
Number of holders
-
88
-
Value change
-
+$5,607,300
-
Number of buys
-
57
-
Number of sells
-
15
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
-
Newer quarter:
Q1 2017
-
Previous quarter:
Q3 2016
Recent filing periods for CUSIP 71714G102:
Institutional Holders of PHARMATHENE INC - COM (PIP) as of Q4 2016
As of 31 Dec 2016,
PHARMATHENE INC - COM (PIP) was held by
88 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
27,725,997 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, PRESCOTT GROUP CAPITAL MANAGEMENT, L.L.C., Nantahala Capital Management, LLC, BlackRock Fund Advisors, VANGUARD GROUP INC, Northern Right Capital Management, L.P., STATE STREET CORP, DEUTSCHE BANK AG\, BRIDGEWAY CAPITAL MANAGEMENT INC, and ACADIAN ASSET MANAGEMENT LLC.
This page lists
88
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.